Thulium laser enucleation of the prostate (ThuLEP): Transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction

World Journal of Urology

Volumn 28, Issue 1, 2010, Pages 45-51

  Herrmann, Thomas R W ^a   Bach, T ^b   Imkamp, F ^a   Georgiou, A ^c   Burchardt, M ^c   Oelke, M ^a,d   Gross, A J ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ASKLEPIOS HOSPITAL BARMBEK   (Germany)

^c University Dental Clinic   (Germany)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Benign prostatic enlargement; Benign prostatic obstruction; HoLEP; Holmium; Laser prostatectomy; Thulium; Treatment

Indexed keywords

THULIUM;

ARTICLE; HUMAN; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; PROSTATE HYPERTROPHY; PROSTATISM; TRANSURETHRAL RESECTION;

HUMANS; LASER THERAPY; MALE; PROSTATIC HYPERPLASIA; PROSTATISM; THULIUM; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 75849155531     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0503-0     Document Type: Article

References (32)

1. Herrmann TR, Georgiou A, Bach T, Gross AJ, Oelke M (2009) Laser treatments of the prostate vs TURP/open prostatectomy: systematic review of urodynamic data. Minerva Urol Nefrol 61(3): 309-324.
2. Tan AH, Gilling PJ, Kennett KM et al (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 170: 1270.
3. Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1. 94 microm. J Endourol 19(1): 25-31.
4. Bach T, Wezel F, Haecker A, Gross AJ, Michel MS (2009) 70 vs 120 W thulium: yttrium-aluminiumgarnet 2 m continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU [Epub ahead of print]. doi:10.1111/j.1464-410X.2009.09059.x.
5. Bach T, Herrmann TR, Cellarius C, Gross AJ (2007) Bladder neck incision using a 70 W 2 micron continuous wave laser (RevoLix). World J Urol 25(3): 263-267.
6. Bach T, Herrmann TR, Ganzer R, Gross AJ (2007) RevoLix™ vaporesection of the prostate: initial results after 54 patients with an one-year follow-up. World J Urol 25(3): 257-262.
7. Bach T, Herrmann TR, Ganzer R, Blana A, Burchardt M, Gross AJ, Urologe A (2009) Thulium: YAG vaporesection of the prostate: first results. Urologe A 48(5): 529-534.
8. Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ (2009) Feasibility and efficacy of Thulium: YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27(4): 541-545.
9. Bach T, Herrmann TR, Haecker A, Michel MS, Gross A (2009) Thulium: yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int 104(3): 361-364.
10. Bach T, Netsch Ch, Haecker A, Michel MS, Herrmann TRW, Gross AJ (2009) Thulium: YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol [Epub ahead of print].
11. Imkamp F, Bach T, Gross AJ, Kuczyk MA, Herrmann TR (2009) ThuLEP-Thulium laser enucleation of the prostate. J Endourol 23(Suppl 1): 24.
12. McConnel JD, Barry MJ, Bruskewitz RC et al (1994) Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guideline, Number 8. Chapters 10-14. US: Department of Health and Human Services, Public Health Service, Agency for Health Care policy and research.
13. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG (2008) Urology Section of the Bavarian Working Group for Quality Assurance. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10, 654 patients. J Urol 180(1): 246-249.
14. Holtgrewe HL, Valk WL (1962) Factors influencing the mortality, morbidity of transurethral prostatectomy: a study of 2, 015 cases. J Urol 87: 450.
15. Melchior J, Valk WL, Foret JD, Mebust WK (1974) Transurethral prostatectomy: computerized analysis of 2, 223 consecutive cases. J Urol 112: 634.
16. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications: A cooperative study of 13 participating institutions evaluating 3, 885 patients. J Urol 141: 243-247.
17. Hiraoka Y, Akimoto M (1989) Transurethral enucleation of benign prostatic hyperplasia. J Urol 142(5): 1247-1250.
18. Fraundorfer MR, Gilling PJ (1998) Holmium: YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 33(1): 69-72.
19. Teichmann HO, Herrmann TR, Bach T (2007) Technical aspects of lasers in urology. World J Urol 25(3): 221-225.
20. Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, Häcker A (2008) Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 22(5): 1041-1045.
21. Wendt-Nordahl G, von Löwenstern K, Honeck P et al (2008) Ex-vivo comparison of bipolar plasma-kinetic vaporization of the prostate to low power and high power Greenlight laser. J Endourol 22(Suppl 1): A19, BR4-14.
22. Bach T, Wezel F, Haecker A, Gross AJ, Michel MS (2009) 70 vs 120 W thulium: yttrium-aluminiumgarnet 2 m continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU [Epub ahead of print]. doi: 10.1111/j.1464-410X.2009.09059.x.
23. El-Hakim A, Elhilali MM (2002) Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 90(9): 863-869.
24. Tinmouth WW, Habib E, Kim SC, Kuo RL, Paterson RF, Terry CL, Elhilali M, Lingeman JE (2005) Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection? J Endourol 19(5): 550-554.
25. Ozden C, Inal G, Adsan O, Yazici S, Ozturk B, Cetinkaya M (2003) Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA. Urol Int 71: 150.
26. Aus G, Bergdahl S, Frösing R, Lodding P, Pileblad E, Hugosson J (1996) Reference range of prostatespecific antigen after transurethral resection of the prostate. Urology 47: 529.
27. Elmansy HM, Elzayat EA, Sampalis JS, Elhilali MM (2009) Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy. Urology 74(5): 1105-1110.
28. van Iersel MP, Thomas CM, Witjes WP, de Graaf R, de la Rosette JJ, Debruyne FM (1996) Clinical implications of the rise and fall of prostate specific antigen after laser prostatectomy. Br J Urol 78: 742.
29. Hai MA, Malek RS (2003) Photoselective vaporization of the prostate: Initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 17: 93.
30. Te AE, Malloy TR, Stein BS et al (2004) Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 172: 1404.
31. Hamann MF, Naumann CM, Seif C, van der Horst C, Jünemann KP, Braun PM (2008) Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up. Eur Urol 54(4): 902-907.
32. Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, Zhang L, Wang XX (2009) Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow- up. BJU Int 103(3): 352-356.